{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:58:05Z","timestamp":1761512285363},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1989,2,1]],"date-time":"1989-02-01T00:00:00Z","timestamp":602294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1989,2]]},"DOI":"10.1007\/bf00609190","type":"journal-article","created":{"date-parts":[[2006,8,17]],"date-time":"2006-08-17T21:32:32Z","timestamp":1155850352000},"page":"165-174","source":"Crossref","is-referenced-by-count":19,"title":["Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal"],"prefix":"10.1007","volume":"36","author":[{"given":"L. O.","family":"Eriksson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"W\u00e5hlin-Boll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Odar-Cederl\u00f6f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Lindholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Melander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"Suppl","key":"BF00609190_CR1","first-page":"9","volume":"1","author":"K Brune","year":"1977","unstructured":"Brune K, Graf P, Rainsford KD (1977) A pharmacokinetic approach of the understanding of therapeutic effects and side-effects of salicylates. In: Rainsford KD, Brune K, Whitehouse MW (eds) Aspirin and related drugs: Their actions and uses. Agents Actions [Suppl] 1: 9\u201326","journal-title":"Agents Actions"},{"key":"BF00609190_CR2","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1111\/j.1365-2125.1980.tb01810.x","volume":"10","author":"K Brune","year":"1980","unstructured":"Brune K, Rainsford KD, Schweitzer A (1980) Biodistribution of mild analgesics. Br J Clin Pharmacol 10: 2795\u20132845","journal-title":"Br J Clin Pharmacol"},{"key":"BF00609190_CR3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/phar.1983.3.2p2.55","volume":"3","author":"ER Umbenhauer","year":"1983","unstructured":"Umbenhauer ER (1983) Diflunisal in the treatment of pain of osteoarthritis. Pharmacother 3: 555\u2013605","journal-title":"Pharmacother"},{"key":"BF00609190_CR4","first-page":"229","volume":"17","author":"G Besselar","year":"1975","unstructured":"Besselar G, Steelman SL, Tempero KF, Honig W, Brosens Y, Candron J, De Vroey P (1975) Analgesic efficacy of MK-647, a novel salicylate. Clin Pharmacol Ther 17: 229","journal-title":"Clin Pharmacol Ther"},{"key":"BF00609190_CR5","first-page":"224","volume":"253","author":"SL Steelman","year":"1975","unstructured":"Steelman SL, Tempers KF, Besselaar GH, Honig W, De Vroey P, Bahons I, Muller W, Cheries A (1975) The analgesic activity of diflunisal, a novel salicylate, in various pain models. Clin Res 253: 224","journal-title":"Clin Res"},{"key":"BF00609190_CR6","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1161\/01.CIR.72.6.1177","volume":"72","author":"C Patrono","year":"1985","unstructured":"Patrono C, Ciabattoni G, Patrignani P (1985) Clinical pharmacology of platelet cyclooxygenase inhibition. Circulation 72: 1177\u20131184","journal-title":"Circulation"},{"key":"BF00609190_CR7","first-page":"375","volume":"4","author":"CT Smith Sibinga","year":"1977","unstructured":"Smith Sibinga CT (1977) Effect of diflunisal on platelet function and blood coagulation. Br J Clin Pharmacol 4: 375\u2013385","journal-title":"Br J Clin Pharmacol"},{"key":"BF00609190_CR8","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/clpt.1981.176","volume":"30","author":"DL Green","year":"1981","unstructured":"Green DL, Davies RO, Holmes GI, Kohl H, Lee RB, Reynolds N, Schmid FR, Tsao C (1981) Effect of diflunisal on platelet function and fecal blood loss. Clin Pharmacol Ther 30: 378\u2013384","journal-title":"Clin Pharmacol Ther"},{"key":"BF00609190_CR9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1185\/03007997809108994","volume":"5","author":"PA Dieppe","year":"1978","unstructured":"Dieppe PA (1978) Nephrotoxicity studies on aspirin and diflunisal. Curr Med Res Opin 5: 575\u2013579","journal-title":"Curr Med Res Opin"},{"key":"BF00609190_CR10","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/bmj.2.6138.664","volume":"2","author":"PA Dieppe","year":"1979","unstructured":"Dieppe PA, Doyle DV, Burry HC (1979) Renal damage during tresatment with antirheumatic drugs. Br Med J 2: 664","journal-title":"Br Med J"},{"key":"BF00609190_CR11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/rheumatology\/18.1.53","volume":"18","author":"PA Dieppe","year":"1979","unstructured":"Dieppe PA, Huskisson EC (1979) Diflunisal and aspirin: A comparison of efficacy and nephrotoxicity in osteoarthritis. Rheumatol Rehabil 18: 53\u201356","journal-title":"Rheumatol Rehabil"},{"key":"BF00609190_CR12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/03009748109095317","volume":"10","author":"L Lindholm","year":"1981","unstructured":"Lindholm L, Ekdahl C, H\u00e5kansson E, Melander A, Olsson S, Svensson B, W\u00e5hlin-Boll E (1981) Comparison of diflunisal and acetylsalicylic acid in patients with rheumatoid arthritis. Scand J Rheumatol 10: 289\u2013295","journal-title":"Scand J Rheumatol"},{"key":"BF00609190_CR13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/rheumatology\/19.2.126","volume":"19","author":"M Silva De","year":"1980","unstructured":"De Silva M, Hazleman BL, Dippy JE (1980) Diflunisal and aspirin: A comparative study in rheumatoid arthritis. Rheumatol Rehabil 19: 126\u2013130","journal-title":"Rheumatol Rehabil"},{"key":"BF00609190_CR14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/bmj.280.6207.75","volume":"280","author":"I Caruso","year":"1980","unstructured":"Caruso I, Bianchi-Porro G (1980) Gastroscopic evaluation of anti-inflammatory agents. Br Med J 280: 75\u201378","journal-title":"Br Med J"},{"key":"BF00609190_CR15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/ard.30.2.166","volume":"30","author":"R Cockel","year":"1971","unstructured":"Cockel R, Kendall MJ, Becker JF, Hawkins CF (1971) Serum biochemical values in rheumatoid disease. Ann Rheum Dis 30: 166\u2013170","journal-title":"Ann Rheum Dis"},{"key":"BF00609190_CR16","first-page":"158","volume":"19","author":"RE Schneider","year":"1981","unstructured":"Schneider RE, Bishop H, Kendall MJ, Quarterman CP (1981) Effect of inflammatory disease on plasma concentrations of three beta-adrenoreceptor blocking drugs. Int J Clin Pharmacol Ther Toxicol 19: 158\u2013162","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"BF00609190_CR17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF00637622","volume":"21","author":"PR Crock","year":"1982","unstructured":"Crock PR, Willis JV, Kendall MJ, Jack DB, Fowler PD (1982) The pharmacokinetics of diclofenac sodium in patients with active rheumatoid disease. Eur J Clin Pharmacol 21: 331\u2013334","journal-title":"Eur J Clin Pharmacol"},{"key":"BF00609190_CR18","first-page":"180","volume":"250","author":"KD Rainford","year":"1981","unstructured":"Rainford KD, Schweitzer A, Brune K (1981) Autoradiographic and biochemical observations on the distribution of nonsteroid antiinflammatory drugs. Arch Int Pharmacodyn 250: 180\u2013194","journal-title":"Arch Int Pharmacodyn"},{"key":"BF00609190_CR19","first-page":"453","volume":"3","author":"DJ Tocco","year":"1975","unstructured":"Tocco DJ, Breault GO, Zacchei AG, Steelman SL, Derrier CV (1975) Physiological disposition and metabolism of 5-(2\u2032,4\u2032-difluoraphenyl) salisylic acid, a new salicylate. Drug Metab Dispos 3: 453\u2013456","journal-title":"Drug Metab Dispos"},{"key":"BF00609190_CR20","unstructured":"Yeh KE, Tocco DJ (1982) Nonlinear pharmacokinetics of diflunisal (abstr.) Proc Acad Pharm Sci 52"},{"key":"BF00609190_CR21","first-page":"402","volume":"235","author":"JH Lin","year":"1985","unstructured":"Lin JH, Hook KF, Yea KC, Duggan DE (1985) Dose-dependent pharmacokinetics of diflunisal in rats: Dual effects of protein binding and metabolism. J Pharmacol Exp Ther 235: 402\u2013406","journal-title":"J Pharmacol Exp Ther"},{"key":"BF00609190_CR22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2125.1979.tb00932.x","volume":"7","author":"R Verbeeck","year":"1979","unstructured":"Verbeeck R, Tjandramaga TB, Mullie A, Verbesselt R, Verberckmoes R, De Schepper PJ (1979) Biotransformation of diflunisal and renal excretion of its glucoronides in renal insufficiency. Br J Clin Pharmacol 7: 273\u2013282","journal-title":"Br J Clin Pharmacol"},{"key":"BF00609190_CR23","doi-asserted-by":"crossref","unstructured":"Elseviers MM, Verpooten GA, De Broe ME (1987) Interpretation of creatinine clearance. Lancet: 457","DOI":"10.1016\/S0140-6736(87)90167-X"},{"key":"BF00609190_CR24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF00615408","volume":"20","author":"E W\u00e5hlin-Boll","year":"1981","unstructured":"W\u00e5hlin-Boll E, Brantmark B, Hanson A, Melander A, Nilsson C (1981) High-pressure liquid chromatographic determination of acetylsalicylic acid, salicylic acid, diflunisal, indomethacin, indoprofen and indobufen. Eur J Clin Pharmacol 20: 375\u2013378","journal-title":"Eur J Clin Pharmacol"},{"key":"BF00609190_CR25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2125.1979.tb00997.x","volume":"7","author":"R Verbeeck","year":"1979","unstructured":"Verbeeck R, Tjandramaga TB, Mullie A, Verbesselt R, De Schepper PJ (1979) Effect of aluminium hydroxide on diflunisal absorption. Br J Clin Pharmacol 7: 519\u2013522","journal-title":"Br J Clin Pharmacol"},{"key":"BF00609190_CR26","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/clpt.1981.177","volume":"30","author":"JA Tobert","year":"1981","unstructured":"Tobert JA, De Schepper PJ, Tjandramaga TB, Mullie A, Buntinx AP, Meisinger MAP, Huber PB, Hall TLP, Yeh KC (1981) Effect of antacids on the bioavailability of diflunisal in the fasting and postprandial states. Clin Pharmacol Ther 30: 385\u2013389","journal-title":"Clin Pharmacol Ther"},{"key":"BF00609190_CR27","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0025-7125(16)32094-6","volume":"58","author":"L Dettli","year":"1974","unstructured":"Dettli L (1974) Individualization of drug dosage in patients with renal disease. Med Clin North Am 58: 977\u2013985","journal-title":"Med Clin North Am"},{"key":"BF00609190_CR28","first-page":"76","volume":"11","author":"P Spring","year":"1975","unstructured":"Spring P (1975) Calculation of drug dosage regimens in patients with renal disease: A new nomographic method. Int J Clin Pharmacol 11: 76\u201380","journal-title":"Int J Clin Pharmacol"},{"key":"BF00609190_CR29","first-page":"43","volume-title":"Salicylates, an international symposium","author":"TB Bayles","year":"1962","unstructured":"Bayles TB (1962) Plasma salicylate levels in rheumatoid arthritis. In: Dixon A, Martin BK, Smith MJH, Wood PHN (eds) Salicylates, an international symposium. Churchill, London, pp 43\u201346"},{"key":"BF00609190_CR30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/cpt1979261122","volume":"26","author":"JM Grindel","year":"1979","unstructured":"Grindel JM, Migdalof BH, Plostnieks J (1979) Absorption and excretion of tolmetin arthritic patients. Clin Pharmacol Ther 26: 122\u2013128","journal-title":"Clin Pharmacol Ther"},{"key":"BF00609190_CR31","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/cpt1975175599","volume":"17","author":"ML Selley","year":"1975","unstructured":"Selley ML, Glass J, Triggs EJ, Thomas J (1975) Pharmacokinetic studies of tolmetin in man. Clin Pharmacol Ther 17: 599\u2013605","journal-title":"Clin Pharmacol Ther"},{"key":"BF00609190_CR32","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/ard.28.6.590","volume":"28","author":"IM Chalmers","year":"1969","unstructured":"Chalmers IM, Pohl JEF, Platt DS (1969) The evaluation in man of fenclozic acid, a new anti-inflammatory agent. Serum concentration studies in healthy individuals and in patients with rheumatoid arthritis. Ann Rheum Dis 28: 590\u2013594","journal-title":"Ann Rheum Dis"},{"key":"BF00609190_CR33","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/cpt1975183364","volume":"18","author":"G Alv\u00e1n","year":"1975","unstructured":"Alv\u00e1n G, Orme M, Bertilsson L, Ekstrand R, Palm\u00e9r L (1975) Pharmacokinetics of indomethacin. Clin Pharmacol Ther 18: 364\u2013373","journal-title":"Clin Pharmacol Ther"},{"key":"BF00609190_CR34","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/ard.38.2.128","volume":"38","author":"N Baber","year":"1979","unstructured":"Baber N, Halliday LDC, Van Den Heuvel WJA, Walker RW, Sibeon R, Keenan HP, Littler T, Orme M (1979) Indomethacin in rheumatoid arthritis: Clinical effects, pharmacokinetics and non-responders. Ann Rheum Dis 38: 128\u2013137","journal-title":"Ann Rheum Dis"},{"key":"BF00609190_CR35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0002-9343(54)90333-2","volume":"16","author":"BB Brodie","year":"1954","unstructured":"Brodie BB, Lowman EW, Burns JJ, Lee PR, Chenhin T, Goldman A, Weiner M, Steele MJ (1954) Observations on the anti-rheumatic and physiologic effects of phenylbutazone and some comparisons with cortisone. Am J Med 16: 181\u2013190","journal-title":"Am J Med"},{"key":"BF00609190_CR36","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF00566533","volume":"11","author":"J Aarbacke","year":"1977","unstructured":"Aarbacke J, Bakke OM, Milde EJ, Davies DS (1977) Disposition and oxidative metabolism of phenylbutazone in man. Eur J Clin Pharmacol 11: 359\u2013366","journal-title":"Eur J Clin Pharmacol"},{"key":"BF00609190_CR37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00547372","volume":"29","author":"L Rooney","year":"1985","unstructured":"Rooney L, Kendall MJ, Main A, Hosie J, John VA (1985) Pharmacokinetics of pirprofen in young volunteers and elderly patients. Eur J Clin Pharmacol 29: 73\u201377","journal-title":"Eur J Clin Pharmacol"},{"key":"BF00609190_CR38","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/clpt.1980.89","volume":"27","author":"RK Verbeeck","year":"1980","unstructured":"Verbeeck RK, De Schepper PJ (1980) Influence of chronic renal failure och hemodialysis on diflunisal plasma protein binding. Clin Pharmacol Ther 27: 628\u2013635","journal-title":"Clin Pharmacol Ther"},{"key":"BF00609190_CR39","first-page":"8","volume":"1","author":"L Dettli","year":"1977","unstructured":"Dettli L (1977) Elimination kinetics and dosage adjustment of drugs in patients with kidney disease. Progr Pharmacol 1: 8\u201317","journal-title":"Progr Pharmacol"},{"key":"BF00609190_CR40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1620\/tjem.105.45","volume":"105","author":"K Shimomura","year":"1971","unstructured":"Shimomura K, Kamata O, Keki S, Ida S, Oguri K, Yoshimura H, Tsukamoto H (1971) Analgesic effect of morphine glucuronides. Tohoku J Exp Med 105: 45\u201352","journal-title":"Tohoku J Exp Med"},{"key":"BF00609190_CR41","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1136\/bmj.292.6535.1548","volume":"292","author":"RJ Osborne","year":"1986","unstructured":"Osborne RJ, Joel SP, Slevin ML (1986) Morphine intoxication in renal failure: The role of morphine-6-glucuronide. Br Med J 292: 1548\u20131549","journal-title":"Br Med J"},{"key":"BF00609190_CR42","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2125.1979.tb01055.x","volume":"8","author":"G Levy","year":"1979","unstructured":"Levy G (1979) Decreased body clearance of diflunisal in renal insufficiency \u2014 an alternative explanation. Br J Clin Pharmacol 8: 601","journal-title":"Br J Clin Pharmacol"},{"key":"BF00609190_CR43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2125.1980.tb01744.x","volume":"10","author":"EM Faed","year":"1980","unstructured":"Faed EM (1980) Decreased clearance of diflunisal in renal insufficiency \u2014 an alternative explanation. Br J Clin Pharmacol 10: 185\u2013185","journal-title":"Br J Clin Pharmacol"},{"key":"BF00609190_CR44","first-page":"52","volume":"40","author":"I Odar-Cederl\u00f6f","year":"1977","unstructured":"Odar-Cederl\u00f6f I, Vessman J, Alvan G, Sj\u00f6qvist F (1977) Oxazepam disposition in uremic patients. Acta Pharmacol Toxicol 40: 52\u201362","journal-title":"Acta Pharmacol Toxicol"},{"key":"BF00609190_CR45","first-page":"87","volume":"15","author":"M Blum","year":"1981","unstructured":"Blum M, Bauminger S, Algueti A, Kish E, Ayalon D, Aviram A (1981) Urinary prostaglandin E2 in chronic renal disease. Clin Nephrol 15: 87\u201389","journal-title":"Clin Nephrol"},{"key":"BF00609190_CR46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00005792-198405000-00003","volume":"63","author":"S Garella","year":"1984","unstructured":"Garella S, Matarese RA (1984) Renal effects of prostaglandins and clinical adverse effects of non-steroidal anti-inflammatory agents. Medicine 63: 165\u2013181","journal-title":"Medicine"},{"key":"BF00609190_CR47","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/0002-9343(85)90223-2","volume":"78","author":"J Carmichael","year":"1985","unstructured":"Carmichael J, Shankel SW (1985) Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function. Am J Med 78: 992\u20131000","journal-title":"Am J Med"},{"key":"BF00609190_CR48","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF00499844","volume":"315","author":"K Brune","year":"1981","unstructured":"Brune K (1981) Inhibition by anti-inflammatory drugs of prostaglandin production in cultured macrophages. Naunyn Schmiedebergs Arch Pharmacol 315: 269\u2013279","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"BF00609190_CR49","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2125.1977.tb04509.x","volume":"4","author":"PW Majerus","year":"1977","unstructured":"Majerus PW, Stanford N (1977) Comparative effects of aspirin and diflunisal on prostaglandin synthetase from human platelets and sheep seminal vesicles. Br J Clin Pharmacol 4: 155\u2013183","journal-title":"Br J Clin Pharmacol"},{"key":"BF00609190_CR50","first-page":"19","volume-title":"Prostaglandin synthetase inhibitors","author":"TY Shen","year":"1974","unstructured":"Shen TY, Ham EA, Cirillo VJ, Zanetti M (1974) Structure-activity relationship of certain prostaglandin synthetase inhibitors. In: Robinson HJ, Vane IR (eds) Prostaglandin synthetase inhibitors. Raven, New York, pp 19\u201331"},{"key":"BF00609190_CR51","first-page":"111","volume-title":"Prostaglandin and tromboxanes. NATO advanced study institute series. A life sciences","author":"TY Shen","year":"1977","unstructured":"Shen TY (1977) Prostaglandin synthetase inhibitors. In: Berti F, Samuelsson B, Velo GP (eds) Prostaglandin and tromboxanes. NATO advanced study institute series. A life sciences. Plenum, New York, pp 111\u2013136"},{"key":"BF00609190_CR52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/030006057900700110","volume":"7","author":"P Schultz","year":"1979","unstructured":"Schultz P, Perrier CV, Ferber-Perret F, Van den Heuvel WJ, Steelman SL (1979) Diflunisal, a new acting analgesic and prostaglandin inhibitor: Effect of concomitant acetylsalicylic acid therapy on ototoxicity and on disposition of both drugs. J Int Med Res 7: 61\u201368","journal-title":"J Int Med Res"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00609190.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00609190\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00609190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T03:24:35Z","timestamp":1554434675000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00609190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,2]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1989,2]]}},"alternative-id":["BF00609190"],"URL":"https:\/\/doi.org\/10.1007\/bf00609190","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,2]]}}}